New addition to handle material transfer agreements
technology ventures
New use for OMRF brain cancer treatment could extend lives
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF hosts national biotechnology forum
Visiting attendees represented some of the top names in in the industry.
Tech Ventures team adds two
Sam McNeal, Ph.D., and Michael Sweeney have joined the Technology Ventures staff.
Venture capital, biotech execs converge on OMRF
Networking, lab tours highlight first OMRF BioVenture Forum
New OMRF vice president focuses on bringing discoveries to the world
Technology Ventures works to pair scientists with industry partners.
